药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Cefaloridine
Cefaloridine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Ceftaroline fosamil
Ceftaroline fosamil may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Ceftobiprole
Ceftobiprole may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Latamoxef
Latamoxef may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Cephalothin Group
Cephalothin Group may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Hydrolyzed Cephalothin
Hydrolyzed Cephalothin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Cefpodoxime
Cefpodoxime may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Cefoxitin
Cefoxitin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Cefotetan
Cefotetan may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Cefonicid
Cefonicid may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Insulin detemir
Opipramol
The risk or severity of adverse effects can be increased when Opipramol is combined with Levomilnacipran.
Insulin detemir
Imipramine oxide
The risk or severity of adverse effects can be increased when Imipramine oxide is combined with Levomilnacipran.
Insulin detemir
Melitracen
The risk or severity of adverse effects can be increased when Melitracen is combined with Levomilnacipran.
Insulin detemir
Quinupramine
The risk or severity of adverse effects can be increased when Quinupramine is combined with Levomilnacipran.
Insulin detemir
Amitriptylinoxide
The risk or severity of adverse effects can be increased when Amitriptylinoxide is combined with Levomilnacipran.
Insulin detemir
Dimetacrine
The risk or severity of adverse effects can be increased when Dimetacrine is combined with Levomilnacipran.
Insulin detemir
Iprindole
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Iprindole.
Insulin detemir
Lofepramine
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Lofepramine.
Insulin detemir
Dibenzepin
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Dibenzepin.
Insulin detemir
Oxaprotiline
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Oxaprotiline.